Sign in

CIK 0001464521 · Non-accelerated filer<br>Emerging growth company

Heartflow, Inc.

Sign in to watch
Ticker
HTFL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
260506743
Phone
650-241-1221
Business address
135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
Former names
Cardiovascular Simulation, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,358,935
in 2 filings, $2.4M under 10b5-1 plans

Net −$2,358,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 76 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-10 Farquhar John C.M. Chief Executive Officer Option exercise 10b5-1 +15,620 $2.22 $35K 290,883
2026-11-10 Farquhar John C.M. Chief Executive Officer Sale 10b5-1 −38,900 $55.74 $2.2M 251,983
2026-11-10 Farquhar John C.M. Chief Executive Officer Option exercise · Stock Option 10b5-1 −15,620 1,969,017
2026-11-09 Verghese Vikram Chief Financial Officer Sale 10b5-1 −3,587 $53.15 $191K 149,587
2026-11-06 Farquhar John C.M. Chief Executive Officer Shares withheld for taxes 10b5-1 −7,751 $52.40 $406K 275,263
2026-11-06 Verghese Vikram Chief Financial Officer Shares withheld for taxes 10b5-1 −2,009 $52.40 $105K 153,174
2026-11-06 Rogers Campbell Chief Medical Officer Shares withheld for taxes −2,270 $52.40 $119K 71,183
2026-11-06 Jones Marie L. Chief Accounting Officer Shares withheld for taxes −568 $52.40 $30K 32,403
2026-09-08 Jones Marie L. Chief Accounting Officer Grant or award +795 $19.70 $16K 32,971

Page 1 of 1 · 9 trades